FDA approves first mRNA flu vaccine for people over 50
Moderna’s mRNA-1010 flu vaccine has received FDA approval for adults aged 50 and older, marking it as the first mRNA-based flu vaccine in the U.S. It demonstrates 26.6% higher effectiveness than standard vaccines. While adverse events were more frequent, most… Read More »FDA approves first mRNA flu vaccine for people over 50









